rs80356734

Variant summary

Our verdict is Pathogenic. The variant received 16 ACMG points: 17P and 1B. PS3PM1PM2PP2PP5_Very_StrongBP4

The NM_007375.4(TARDBP):​c.1055A>G​(p.Asn352Ser) variant causes a missense change. The variant allele was found at a frequency of 0.00000137 in 1,458,662 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). ClinVar reports functional evidence for this variant: "SCV002242980: Experimental studies have shown that this missense change affects TARDBP function (PMID:22406069, 24440310).". Another variant affecting the same amino acid position, but resulting in a different missense (i.e. N352D) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 0.0000014 ( 0 hom. )

Consequence

TARDBP
NM_007375.4 missense

Scores

2
16

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:9O:1

Conservation

PhyloP100: 3.83

Publications

53 publications found
Variant links:
Genes affected
TARDBP (HGNC:11571): (TAR DNA binding protein) HIV-1, the causative agent of acquired immunodeficiency syndrome (AIDS), contains an RNA genome that produces a chromosomally integrated DNA during the replicative cycle. Activation of HIV-1 gene expression by the transactivator Tat is dependent on an RNA regulatory element (TAR) located downstream of the transcription initiation site. The protein encoded by this gene is a transcriptional repressor that binds to chromosomally integrated TAR DNA and represses HIV-1 transcription. In addition, this protein regulates alternate splicing of the CFTR gene. A similar pseudogene is present on chromosome 20. [provided by RefSeq, Jul 2008]
MASP2 (HGNC:6902): (MBL associated serine protease 2) This gene encodes a member of the peptidase S1 family of serine proteases. The encoded preproprotein is proteolytically processed to generate A and B chains that heterodimerize to form the mature protease. This protease cleaves complement components C2 and C4 in order to generate C3 convertase in the lectin pathway of the complement system. The encoded protease also plays a role in the coagulation cascade through cleavage of prothrombin to form thrombin. Myocardial infarction and acute stroke patients exhibit reduced serum concentrations of the encoded protein. Alternative splicing results in multiple transcript variants, at least one of which encodes an isoform that is proteolytically processed. [provided by RefSeq, Feb 2016]
MASP2 Gene-Disease associations (from GenCC):
  • immunodeficiency due to MASP-2 deficiency
    Inheritance: AR Classification: STRONG Submitted by: Laboratory for Molecular Medicine

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 16 ACMG points.

PS3
PS3 evidence extracted from ClinVar submissions: SCV002242980: Experimental studies have shown that this missense change affects TARDBP function (PMID: 22406069, 24440310).
PM1
In a hotspot region, there are 5 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 8 uncertain in NM_007375.4
PM2
Very rare variant in population databases, with high coverage;
PP2
Missense variant in the TARDBP gene, where missense mutations are typically associated with disease (based on misZ statistic). The gene has 22 curated pathogenic missense variants (we use a threshold of 10). The gene has 2 curated benign missense variants. Gene score misZ: 3.7095 (above the threshold of 3.09). Trascript score misZ: 5.3115 (above the threshold of 3.09). GenCC associations: The gene is linked to amyotrophic lateral sclerosis type 10, amyotrophic lateral sclerosis, frontotemporal dementia with motor neuron disease, inclusion body myositis.
PP5
Variant 1-11022464-A-G is Pathogenic according to our data. Variant chr1-11022464-A-G is described in ClinVar as Pathogenic/Likely_pathogenic. ClinVar VariationId is 21468.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP4
Computational evidence support a benign effect (MetaRNN=0.30383795). . Strength limited to SUPPORTING due to the PP5.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_007375.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TARDBP
NM_007375.4
MANE Select
c.1055A>Gp.Asn352Ser
missense
Exon 6 of 6NP_031401.1Q13148-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TARDBP
ENST00000240185.8
TSL:1 MANE Select
c.1055A>Gp.Asn352Ser
missense
Exon 6 of 6ENSP00000240185.4Q13148-1
TARDBP
ENST00000649624.1
c.768+287A>G
intron
N/AENSP00000497327.1A0A0A0N0M3
TARDBP
ENST00000639083.1
TSL:5
c.1055A>Gp.Asn352Ser
missense
Exon 6 of 6ENSP00000491203.1Q13148-1

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
AF:
0.00000137
AC:
2
AN:
1458662
Hom.:
0
Cov.:
31
AF XY:
0.00
AC XY:
0
AN XY:
724932
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33422
American (AMR)
AF:
0.00
AC:
0
AN:
44638
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26072
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39628
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86206
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53396
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5750
European-Non Finnish (NFE)
AF:
0.00000180
AC:
2
AN:
1109312
Other (OTH)
AF:
0.00
AC:
0
AN:
60238
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.425
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
Cov.:
33
Alfa
AF:
0.00
Hom.:
0

ClinVar

ClinVar submissions
Significance:Pathogenic/Likely pathogenic
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
4
-
-
not provided (4)
3
-
-
Amyotrophic lateral sclerosis type 10 (4)
1
-
-
Amyotrophic lateral sclerosis type 10;C3150169:FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, TARDBP-RELATED (1)
1
-
-
TARDBP-related disorder (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.052
BayesDel_addAF
Benign
-0.042
T
BayesDel_noAF
Benign
-0.30
CADD
Benign
17
DANN
Benign
0.96
DEOGEN2
Benign
0.32
T
Eigen
Benign
-0.21
Eigen_PC
Benign
0.039
FATHMM_MKL
Uncertain
0.91
D
LIST_S2
Benign
0.85
D
M_CAP
Benign
0.022
T
MetaRNN
Benign
0.30
T
MetaSVM
Benign
-0.56
T
MutationAssessor
Benign
0.20
N
PhyloP100
3.8
PrimateAI
Uncertain
0.66
T
PROVEAN
Benign
-1.1
N
REVEL
Benign
0.28
Sift
Benign
0.60
T
Sift4G
Benign
0.38
T
Polyphen
0.0
B
Vest4
0.53
MutPred
0.74
Gain of phosphorylation at N352 (P = 0.033)
MVP
0.83
MPC
0.73
ClinPred
0.68
D
GERP RS
5.8
PromoterAI
0.0044
Neutral
Varity_R
0.44
gMVP
0.69
Mutation Taster
=22/78
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs80356734; hg19: chr1-11082521; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.